Macular Degeneration News and Research RSS Feed - Macular Degeneration News and Research

Macular degeneration is a disease associated with aging that gradually destroys sharp, central vision. Central vision is needed for seeing objects clearly and for common daily tasks such as reading and driving.
Clinical trial to assess safety of using umbilical cord cells to treat macular degeneration

Clinical trial to assess safety of using umbilical cord cells to treat macular degeneration

UIC is part of a national phase 2 clinical trial to evaluate the safety and tolerability of using cells derived from multipotent umbilical cord cells to treat age-related macular degeneration, the most common cause of vision loss in people over 55. [More]
Study pinpoints how immune abnormalities in retina may lead to macular degeneration

Study pinpoints how immune abnormalities in retina may lead to macular degeneration

In a study published this week in the Proceedings of the National Academy of Sciences, a University of Wisconsin-Madison research team pinpoints how immune abnormalities beneath the retina result in macular degeneration, a common condition that often causes blindness. [More]
Nanoscope researchers develop novel VMCO and NOD platform for patients with vision loss

Nanoscope researchers develop novel VMCO and NOD platform for patients with vision loss

According to the World Health Organization, approximately 285 million people are estimated to be visually impaired worldwide. Age-related macular degeneration (AMD) is a major cause of vision loss in aging populations. [More]
Buck researchers find new way for possible treatment of AMD

Buck researchers find new way for possible treatment of AMD

Buck researchers boosted the potency of a broccoli-related compound by ten times and identified it as a possible treatment for age-related macular degeneration (AMD), the leading cause of vision loss affecting more than 10 million older Americans. [More]
Diabetes drug metformin could help reduce toxic acid levels linked to MSUD

Diabetes drug metformin could help reduce toxic acid levels linked to MSUD

Maple Syrup Urine Disease (MSUD) is a rare inherited metabolic disorder involving the dysfunction of an enzyme which breaks down three essential amino acids: leucine, isoleucine and valine. [More]
Routine eye examinations lead to change in vision prescription or care in asymptomatic patients

Routine eye examinations lead to change in vision prescription or care in asymptomatic patients

Do you really need to get your eyes checked—even if you haven't noticed any vision problems or eye-related symptoms? More than half of routine eye examinations in asymptomatic patients lead to a change in vision prescription or other changes in care, according to a study in the June issue of Optometry and Vision Science, official journal of the American Academy of Optometry. [More]
New research could pave way for improving retinal implants

New research could pave way for improving retinal implants

Engineers and neuroscientists at the University of Sheffield have demonstrated for the first time that the cells in the retina carry out key processing tasks. This could pave the way for improving retinal implants and therefore the sight of thousands of people suffering from retinal disorders. [More]
Pain reliever appears to help preserve vision in animal model of retinal degeneration

Pain reliever appears to help preserve vision in animal model of retinal degeneration

A pain medicine that potently activates a receptor vital to a healthy retina appears to help preserve vision in a model of severe retinal degeneration, scientists report. [More]
Eye donations: what stops people? An interview with Rory Passmore

Eye donations: what stops people? An interview with Rory Passmore

Despite a shortage of corneas for transplant purposes, our new research reveals that eyes are the one body part we are least likely to donate. [More]
Complex 36-point therapeutic personalized program can help reverse memory loss in early AD patients

Complex 36-point therapeutic personalized program can help reverse memory loss in early AD patients

Results from quantitative MRI and neuropsychological testing show unprecedented improvements in ten patients with early Alzheimer's disease (AD) or its precursors following treatment with a programmatic and personalized therapy. Results from an approach dubbed metabolic enhancement for neurodegeneration are now available online in the journal Aging. [More]
Buck researchers identify new, potential drug targets for sporadic PD

Buck researchers identify new, potential drug targets for sporadic PD

Research at the Buck Institute shows the same mechanisms that lead to neuronal cell death in mice genetically fated to develop Parkinson's disease (PD) are involved in the much more common sporadic form of the age-related, neurodegenerative disorder that robs people of the ability to move normally. [More]
Small drug-like molecule that alters perception of food may hold key to extending human healthspan

Small drug-like molecule that alters perception of food may hold key to extending human healthspan

Researchers at the Buck Institute have shown a new effect on aging via a small drug-like molecule that alters the perception of food in the nematode C. elegans. Publishing in Aging Cell, researchers "tricked" the worm's metabolism into a state of caloric restriction, extending the animal's lifespan by 50 percent. [More]
Vision Express advises Britons to be 'sun safe' when choosing eyewear

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed. [More]
NIH-funded study finds visual impairment, blindness may double by 2050

NIH-funded study finds visual impairment, blindness may double by 2050

With the youngest of the baby boomers hitting 65 by 2029, the number of people with visual impairment or blindness in the United States is expected to double to more than 8 million by 2050, according to projections based on the most recent census data and from studies funded by the National Eye Institute, part of the National Institutes of Health. [More]
LALES study analyzes risk, prevalence of early and late stage AMD among Latinos

LALES study analyzes risk, prevalence of early and late stage AMD among Latinos

The University of Southern California Roski Eye Institute researchers and clinicians published results of the largest population-based study of adult Latinos and age-related macular degeneration (AMD) in the National Eye Institute-funded "Los Angeles Latino Eye Study." The study, published in JAMA Ophthalmology, is the first to analyze the risk and prevalence of early and late stage AMD and its impact on quality of life for older Latinos. [More]
Report: Protecting eyes from UV exposure not high priority for Americans

Report: Protecting eyes from UV exposure not high priority for Americans

Three-quarters of Americans are concerned about potential eye problems from the sun's ultraviolet rays, yet only 31 percent protect their eyes with sunglasses or other UV-protective eyewear every time they go outside, according to a new nationwide survey released today. The report by The Vision Council, based on a survey of more than 10,000 adults, finds 34 percent of adults have experienced symptoms of prolonged UV exposure, such as eye irritation, trouble seeing, and red or swollen eyes. [More]
Researchers safely transplant stem cells from patient's skin to the eye to restore vision

Researchers safely transplant stem cells from patient's skin to the eye to restore vision

Researchers have safely transplanted stem cells derived from a patient's skin to the back of the eye in an effort to restore vision. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology this week in Seattle, Wash. [More]

Artificial and natural vision successfully integrated for first time in humans

Scientists have successfully implanted a prosthesis that restores some central vision in patients with only limited peripheral vision remaining to them - the first time artificial and natural vision has ever been integrated in humans. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology this week in Seattle, Wash. [More]
NEI-funded study analyzes outcomes of anti-VEGF therapy for AMD

NEI-funded study analyzes outcomes of anti-VEGF therapy for AMD

In a study of nearly 650 people with the eye disease age-related macular degeneration (AMD), half still had vision 20/40 or better, typically good enough to drive or to read standard print, after five years of treatment with anti-VEGF drugs that are injected into the eye. The authors of the study, funded by the National Eye Institute (NEI) at the National Institutes of Health, say those outcomes would have been unimaginable about 10 years ago, prior to the drugs' availability. [More]
NEI to discuss research advances in regenerative medicine for eye disease at ARVO 2016

NEI to discuss research advances in regenerative medicine for eye disease at ARVO 2016

The National Eye Institute (NEI), part of NIH, is participating in the Inaugural Press Conference from the Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2016), the largest gathering of eye and vision researchers in the world, attracting over 11,000 attendees from more than 75 countries. [More]
Advertisement